Ingelvac PRRS MLV

BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
3239 SATELLITE BLVD., BLDG 500, DULUTH, GA, 30096
Telephone: 800-325-9167
Customer Service: 800-243-0127
Fax: 816-236-2717
Website: www.boehringer-ingelheim.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
Ingelvac PRRS® MLV

Boehringer Ingelheim Animal Health

Porcine Reproductive and Respiratory Syndrome Vaccine

Reproductive and Respiratory Forms, Modified Live Virus

This product has been shown to be effective for the vaccination of healthy swine 3 weeks of age or older against reproductive and respiratory disease caused by Porcine Reproductive and Respiratory Syndrome (PRRS) virus. The duration of immunity is at least 4 months. For more information regarding efficacy and safety data go to productdata.aphis.usda.gov.

Recommended for use in healthy swine in PRRS virus positive herds only, per labeled directions.

Directions and dosage: Rehydrate only with the diluent provided; do not mix with other materials. Other diluents may be viricidal.

Insert a vented transfer spike into the enclosed Sterile Diluent bottle. Invert the Ingelvac PRRS MLV bottle over the diluent and slowly insert the transfer spike into the Ingelvac PRRS MLV vaccine bottle, releasing the vacuum. Rotate the bottles and transfer a portion of the diluent to the vaccine vial, sufficient to rehydrate the Ingelvac PRRS MLV vaccine. Again rotate the bottles, still attached by transfer spike, to transfer the reconstituted suspension back into the diluent bottle. Mix with the remaining diluent to complete the total volume. Shake well and use immediately.


Sows and gilts: Using aseptic technique, inject a single 2 mL dose intramuscularly for the reproductive form of PRRS. Sows and gilts may be vaccinated prior to breeding or at any stage of pregnancy. Vaccination can either be population-targeted as a whole-herd vaccination program where all pregnant and nonpregnant sows and gilts are vaccinated every 3-4 months, or individual animal-targeted by vaccination 3 to 4 weeks prior to each breeding, or as directed by your herd veterinarian. Piglets: Using aseptic technique, inject a single 2 mL dose intramuscularly for the respiratory form of PRRS.

Precautions: Store out of direct sunlight at 35-46°F (2-8°C). Do not freeze. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Do not mix with other products, except as specified on the label. In case of anaphylactoid reaction, administer epinephrine. Do not vaccinate breeding age boars. In case of human exposure, contact a physician. Inactivate unused contents before disposal.

Vaccine virus may be shed and transmitted to other populations of swine in contact with vaccinated swine. The duration of potential vaccine virus transmission may vary. Use of the vaccine in herds intended to remain PRRS virus seronegative is contraindicated. Specific herds may be particularly sensitive. Introduction of vaccinated pigs into herds intended to remain PRRS virus seronegative is contraindicated.

Preservative: Neomycin.

Ingelvac PRRS® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. Used under license.

Boehringer Ingelheim Animal Health USA Inc., St. Joseph, MO 64506

Phone: 1 (888) 637-4251

VLN/PCN 124/19T1.20

10 Doses

Rehydrate with 20 mL

This package contains one 10 dose vial of vaccine and one 20 mL vial of sterile diluent.

124534-12

50 Doses

Rehydrate with 100 mL

This package contains one 50 dose vial of vaccine and one 100 mL vial of sterile diluent.

124535-13

250 Doses

Rehydrate with 500 mL

This package contains one 250 dose vial of vaccine and one 500 mL vial of sterile diluent.

1245139-03

CPN: 1028068.5

COLORADO SERUM COMPANY4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216-0428Telephone: 303-295-7527Order Desk: 800-525-2065Fax: 303-295-1923Website: www.colorado-serum.comEmail: colorado-serum@colorado-serum.comTHIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

TETANUS TOXOID-CONCENTRATED

Colorado Serum

Adjuvanted

GENERAL INFORMATION: This product has been shown to be effective for the vaccination of healthy horses, cattle, sheep, goats, and swine against tetanus. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Safety in pregnant animals is unknown.

Tetanus Toxoid is prepared by detoxifying tetanus toxin in such a manner as to allow the antigenic properties to remain intact. Product is purified, concentrated and adjuvanted to provide a low dose effective immunizing agent.

Each serial is tested for purity, safety, and potency in accordance with USDA requirements.

Tetanus is caused by a neurotoxin produced by growth of Clostridium tetani, an anaerobic (lives without air) micro-organism, in necrotic tissue. Affected animals become stiff, have difficulty swallowing, and have an increased pulse rate. Breathing is labored. Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw.

Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw. Thus, the term “lockjaw” is often used. Legs and tail are often stiff with abdominal muscles contracted. Tetanus stricken animals may be unusually sensitive to light and heat. Temperature of the animal generally remains normal, elevating only shortly before death.

Protective antibody levels usually occur about two weeks after the second injection of the primary immunization series. In contrast, administration of Tetanus Antitoxin is recommended for immediate, emergency, passive treatment of exposed animals with unknown vaccination history or with signs of tetanus infection.

DIRECTIONS: Do not vaccinate within 21 days before slaughter. Store at 2-8° C. Do not freeze. Do not mix with other products. Shake well before use. Use entire contents when first opened.

PRECAUTIONS: A transitory local reaction may occur at injection site. Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent. In case of human exposure, consult a physician.

DOSAGE & ADMINISTRATION: For primary immunization, two doses should be administered subcutaneously or intramuscularly approximately 30 days apart. Use intramuscularly for horses as local reactions are more likely to occur if injected subcutaneously.

Horses: 1 ml IM

Cattle: 1 ml SC or IM

Sheep, Goats, Swine: 0.5 ml SC or IM

Historically, annual single dose revaccination has been recommended. Contact veterinarian for advice.

OTHER INFORMATION: Contains thimerosal and formalin as preservatives. Tetanus Toxoid Concentrate is available in single dose size packaged 10 vials to the carton, and in 10 dose vials.

THE PEAK OF QUALITY SINCE 1923

VLN: 188 / PCN: 8601.00

COLORADO SERUM COMPANY, 4950 York Street, Denver, Colorado 80216

303-295-752

www.colorado-serum.com

Contact us for information on other Colorado Serum Company products. Fine Veterinary Products since 1923.

FOR VETERINARY USE ONLY

Order #

10 - 1 ml vials

10 - 1 dose vials

11411

10 ml

10 doses

11415

CPN: 1101033.3